Celldex Therapeutics, Inc.
CLDX
$18.30
$0.502.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 725.28M | 756.00M | 802.32M | 823.85M | 423.60M |
| Total Receivables | 700.00K | 852.00K | 1.53M | 2.67M | 2.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.18M | 21.99M | 8.12M | 8.81M | 5.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 747.16M | 778.84M | 811.98M | 835.32M | 431.69M |
|
|
|||||
| Total Current Assets | 747.16M | 778.84M | 811.98M | 835.32M | 431.69M |
| Net Property, Plant & Equipment | 8.24M | 7.40M | 6.31M | 6.23M | 6.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 27.19M | 27.19M | 27.19M | 27.19M | 27.19M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.75M | 9.75M | 107.00K | 107.00K | 107.00K |
| Total Assets | 792.34M | 823.18M | 845.59M | 868.85M | 465.63M |
|
|
|||||
| Total Accounts Payable | 3.27M | 1.11M | 3.80M | 3.23M | 3.49M |
| Total Accrued Expenses | 33.84M | 28.20M | 18.59M | 17.54M | 22.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.45M | 1.38M | 1.59M | 1.64M | 1.61M |
| Total Finance Division Other Current Liabilities | 942.00K | 1.40M | 3.67M | 3.88M | 3.99M |
| Total Other Current Liabilities | 942.00K | 1.40M | 3.67M | 3.88M | 3.99M |
| Total Current Liabilities | 39.50M | 32.09M | 27.66M | 26.29M | 31.13M |
|
|
|||||
| Total Current Liabilities | 39.50M | 32.09M | 27.66M | 26.29M | 31.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.36M | 1.71M | 796.00K | 470.00K | 928.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.47M | 3.47M | 3.47M | 3.47M | 4.40M |
| Total Liabilities | 45.34M | 37.27M | 31.93M | 30.23M | 36.46M |
|
|
|||||
| Common Stock & APIC | 2.30B | 2.29B | 2.28B | 2.27B | 1.82B |
| Retained Earnings | -1.56B | -1.51B | -1.47B | -1.43B | -1.40B |
| Treasury Stock & Other | 3.31M | 5.29M | 1.78M | 2.24M | 3.31M |
| Total Common Equity | 747.01M | 785.91M | 813.66M | 838.61M | 429.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 747.01M | 785.91M | 813.66M | 838.61M | 429.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 747.01M | 785.91M | 813.66M | 838.61M | 429.17M |
|
|
|||||